This supports overall fat loss (including around the waist)
Zheng J, Xie Y, Ren L, Qi L, Wu L, Pan X et al (2021) GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimers disease
Gallups survey found nearly 70% of current GLP-1 users take FDA-approved brand-name medications, compared with 19% using the generally cheaper, compounded versions
Due to controlled batch production, verification requirements, and research demand, availability may vary over time
However, because its still relatively new, its long-term effectiveness isnt as extensively established compared to the injectable form
As technology to evaluate improves, the likelihood of understanding this phenomenon will as well